In a published memorandum to the US Food and Drug Administration (FDA) and World Health Organization (WHO), scientists and health-care professionals, including President Obama’s appointee to the FDA’s directorate for biologics review, José J Balcells, argue that COVID-19 is a hypodermic injection that causes an array of unwanted drug side effects including heart failure, acute and chronic heart attacks, and death.
OIT has already raised substantial public concern in several European and Canadian studies. At present, there is a decision by the FDA about whether to approve the injection for use to boost blood plasma levels of vitamin A to stimulate a person’s immune system in order to fight off cancer. FDA would approve the therapy or, if the US public outcry prevails, recall the drug and not provide it to the US. OIT claims this would encourage the producers of vitamin A supplements to import the drug.
As well as delaying clinical trials, OIT’s early testing in the animals in which the injection was administered demonstrated an astounding toxicological profile against the little animals in which the drug had been administered. Interestingly, the current FDA deadline for its decision is 7 July 2019.
The above information is taken from the oral presentation at the Congress of the European Society of Cardiology:
WHO report by Professor Kaheni Sudhakar, Prog Nobelist and Instructor, School of Medicine, Shanghai Jiao Tong University, China
Written by Fay Bouvet